ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
2,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
4,2,Dermatitis infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
4,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
